Virtu Financial LLC Acquires New Shares in Encompass Health Co. (NYSE:EHC)

Virtu Financial LLC bought a new position in shares of Encompass Health Co. (NYSE:EHC - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 4,361 shares of the company's stock, valued at approximately $403,000.

A number of other institutional investors have also added to or reduced their stakes in the business. MassMutual Private Wealth & Trust FSB increased its holdings in shares of Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock valued at $27,000 after purchasing an additional 137 shares during the period. CBIZ Investment Advisory Services LLC increased its holdings in Encompass Health by 38.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after buying an additional 127 shares during the period. Tompkins Financial Corp purchased a new position in Encompass Health during the 4th quarter worth approximately $46,000. V Square Quantitative Management LLC lifted its stake in Encompass Health by 43.8% during the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock valued at $54,000 after acquiring an additional 177 shares during the period. Finally, Signaturefd LLC boosted its stake in shares of Encompass Health by 21.6% in the fourth quarter. Signaturefd LLC now owns 704 shares of the company's stock worth $65,000 after buying an additional 125 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company's stock.

Encompass Health Price Performance

Shares of NYSE:EHC traded down $0.39 during trading on Friday, reaching $100.75. The company had a trading volume of 457,600 shares, compared to its average volume of 649,885. The firm's fifty day moving average is $98.67 and its 200 day moving average is $97.46. The firm has a market capitalization of $10.15 billion, a PE ratio of 22.59, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92. Encompass Health Co. has a twelve month low of $78.53 and a twelve month high of $104.55. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05.

Remove Ads

Encompass Health (NYSE:EHC - Get Free Report) last issued its earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. On average, equities analysts forecast that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a $0.17 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a yield of 0.67%. Encompass Health's payout ratio is presently 15.25%.

Insider Buying and Selling

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the business's stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the sale, the chief accounting officer now owns 69,164 shares of the company's stock, valued at $6,798,129.56. The trade was a 6.79 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 2.10% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on EHC shares. KeyCorp increased their target price on shares of Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a research note on Monday, February 10th. William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. Barclays lifted their price target on shares of Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a research note on Friday, February 7th. Royal Bank of Canada reiterated an "outperform" rating and issued a $110.00 price objective on shares of Encompass Health in a report on Tuesday, February 11th. Finally, StockNews.com upgraded shares of Encompass Health from a "hold" rating to a "buy" rating in a report on Saturday, February 15th. Ten research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Buy" and an average target price of $107.67.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.